[Letterer-Siwe disease of prolonged and apparently favorable development].
D001623:Betamethasone / Q000627:therapeutic use; D005260:Female; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy; D006801:Humans; D007223:Infant; D008775:Methylprednisolone / Q000627:therapeutic use
D001623:Betamethasone; D008775:Methylprednisolone
Maladie de Letterer-Siwe d'évolution prolongée et apparemment favorable.